IntelliProve's innovative platform utilizes contactless optical facial scans via smartphone cameras to quickly assess health parameters like heart rate, respiratory rate, and stress.

IntelliProve, a Belgian software startup founded in 2021, has successfully secured €1.25 million in seed funding from a range of investors, including the venture capital firm Miles Ahead and the non-profit organization Wit-Gele Kruis.

The funding round attracted notable tech entrepreneurs such as Jeroen De Wit and Louis Jonckheere, alongside existing investors and business angels.

The company was established by Maxime Mattelin, Tanguy Sanglet, Brecht Dhuyvetters, and Joeri Tulkens, focusing on advanced health monitoring techniques.

This technology employs signal processing and computer vision for real-time health monitoring, offering what the company describes as 'digital biopsies' for preventive care.

IntelliProve's product is CE-marked and ISO27001-certified, designed as a plug-in for digital health platforms, corporate wellness programs, and health insurance sectors.

The company's mission is to enhance health and well-being through objective insights and preventive healthcare strategies, making healthcare more accessible and personalized.

By 2028, IntelliProve aims to conduct 10 billion health checks, significantly impacting healthcare accessibility for millions.

Currently, the company employs a team of eight and plans to double its workforce within a year to support its growth in digital healthcare transformation.

In 2024, IntelliProve expanded its operations to seven European countries and tripled its revenue, serving clients such as Helan and Neutraal Ziekenfonds Vlaanderen.

Luc Burgelman from Miles Ahead praised IntelliProve's innovative approach to preventive healthcare, expressing confidence in its potential to positively impact millions of lives.

Co-founder Brecht Dhuyvetters noted that the recent investment will enable the company to refine its solution and expand its reach across Europe.